Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Pyrilutamide is discussed as an effective hair loss treatment by some users, despite skepticism due to limited data and underwhelming trial results. Users compare it to finasteride, minoxidil, and RU58841, with some expressing interest in its potential as an adjunct treatment.

Minoxidil 5% topical solution may cause eyesight problems, with some users experiencing blurred vision. The discussion also mentions finasteride's potential side effects, including erectile dysfunction, with varied personal experiences.

People are interested in trying clascosterone (Breezula) for hair loss, especially those who are too young for finasteride. Some users express concerns about the cost and prescription requirements, while others discuss alternatives like RU58841.

RU58841 is used for hair loss, with mixed effectiveness and potential side effects like heart issues. Some users find it effective, while others see no results; alternatives like finasteride and dutasteride are also mentioned.

The user shared minimal results from using JXL-069 for hair loss, noting a slight lengthening of vellus hairs and plans to switch to a prodrug variant due to limited effectiveness. They also mentioned using finasteride and minoxidil, which have plateaued in results.

PP405 is expected to be on the market between 2027 and 2030, with phase 3 trials starting in 2026. There is skepticism about its fast-tracking due to its cosmetic nature, and it may appear on the gray market sooner.

Clascoterone solution is in Phase III trials for male androgenetic alopecia, with results expected in the second half of 2025. Commercialization is anticipated in about 2-3 years, but there are concerns about delays and market expectations.

Men with hair loss might have lichen planopilaris (LPP), which can mimic androgenetic alopecia, leading to misdiagnosis and ineffective treatment with finasteride or dutasteride. Proper diagnosis, including biopsies, is crucial to distinguish between androgenetic alopecia and conditions like LPP.

A 24-year-old male experiencing hair loss has been using finasteride, minoxidil, and ketoconazole shampoo without progress. He is considering switching to oral minoxidil and dutasteride, exploring dermarolling, and eliminating dairy from his diet.

The user shared their 12-month hair regrowth progress using 1mg finasteride, 5mg oral minoxidil, and topical minoxidil. They also used a derma stamp weekly and treated seborrheic dermatitis with Mometasone and Nizoral.

Minoxidil may cause facial bloat, wrinkles, and dark circles, with some users experiencing these side effects quickly. Finasteride can cause painful ejaculations and watery semen, but concerns about penis shrinkage are generally unfounded.

Pumpkin seed oil may cause side effects similar to finasteride, such as brain fog, lethargy, and reduced libido, but it hasn't shown positive results for hair loss. Users suggest reducing the dosage or consulting a doctor, and other treatments like finasteride, minoxidil, and hair transplants are mentioned as alternatives.

Topical minoxidil can be dangerous to cats, even with accidental exposure, and users should be cautious to prevent poisoning. Proper precautions, like washing hands and preventing cats from licking treated areas, are essential to minimize risk.

A 57-year-old man with male pattern hair loss and insulin resistance experienced hair regrowth and weight loss after using tirzepatide, without other hair treatments. Dysregulated glucose metabolism is linked to hair loss, with tirzepatide potentially improving hair density by normalizing insulin resistance.

Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

Oral minoxidil is generally effective for hair loss but may cause side effects like heart palpitations and facial puffiness. Users highlight the importance of monitoring blood pressure due to potential cardiovascular risks.

A 21-year-old male has been using dutasteride for 18 months and a topical minoxidil/finasteride solution for 2.5 years, but his hairline continues to recede. He is considering switching back to finasteride, as some users suggest increasing the dutasteride dose or adding other treatments like ketoconazole shampoo.

Topical Clascoterone showed a 539% improvement in hair count compared to placebo, but its effectiveness and safety are debated. Users compared it to minoxidil and finasteride, with mixed opinions on its potential release in 2026 or 2027.

Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.

Starting hair loss treatment early is crucial for better results. Dutasteride and finasteride are effective, with dutasteride often considered superior, while oral minoxidil shows better gains than topical.

Dutasteride is often more effective than finasteride for hair regrowth, though it may cause initial shedding. Many users see positive results after several months, with some combining it with minoxidil for better outcomes.

Some users experience worsening hair loss with dutasteride and improvement after switching back to finasteride, while others find better results with dutasteride. The effectiveness of treatments like finasteride, dutasteride, minoxidil, and RU58841 varies, requiring individuals to try different combinations or dosages to find what works best.

Finasteride can regrow hair but may cause depression and suicidal thoughts in some users. The connection between finasteride and mental health issues is debated, with some attributing it to pre-existing conditions or stress.

The user switched from finasteride and topical minoxidil to dutasteride and oral minoxidil, experiencing some hair shedding but maintaining hair quality. Suggestions include increasing oral minoxidil dosage, considering a hair transplant, and using dermarolling, while some users recommend stopping treatment altogether.

Switching from finasteride to dutasteride for hair loss yields mixed results, with some users experiencing improvements and others facing worsening conditions or side effects like shedding. Patience is advised as dutasteride may take longer to show results, and combining treatments is suggested by some users.

Oral minoxidil is considered effective for hair growth, and some users combine it with microneedling despite mixed opinions on its additional benefits. Concerns about microneedling include potential scarring and lack of conclusive evidence on its effectiveness when used with oral treatments.

OP uses microneedling, Minoxidil, and recently started RU58841 for hair loss. Users suggest adding finasteride, but OP is concerned about side effects.

A 16-year-old female experiencing severe hair loss and sebum buildup, likely due to telogen effluvium and PCOS, is currently using vitamin D3 supplements, Redenser serum, and T follihair supplements. Recommendations include addressing PCOS first and consulting a doctor.

Breezula protects hair follicles from both testosterone and DHT, unlike finasteride, which only protects against DHT. This could potentially lead to significant hair regrowth, similar to results seen in transgender individuals using hormone blockers.

The user has been using 1mg Finasteride daily for six months, experiencing reduced shedding and itchiness but some frontal thinning. They are considering adding Minoxidil and have started dermarolling to enhance results.